Greentrail Capital

Greentrail Capital is a London-based investment firm specializing in growth-stage technology companies. The firm focuses on both publicly traded and private companies, with a global mindset and an emphasis on long-term strategies. Greentrail Capital typically invests in Series A rounds, demonstrating their commitment to supporting companies at critical growth stages.

The firm's portfolio includes Terray Therapeutics, which has raised $60 million to date. Greentrail Capital's team, led by founder Arnau Porto and partners Malcolm Geddes and Mark Carter, seeks to invest in companies with entrepreneurial scalability and those positioned as indispensable utilities. They prioritize technological disruptors and companies poised for inevitable success, offering their expertise to drive growth in the global technology sector.